Bio-Techne Corporation Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bio-Techne Corporation's estimated annual revenue is currently $984.5M per year.(i)
  • Bio-Techne Corporation's estimated revenue per employee is $301,086
  • Bio-Techne Corporation's current valuation is $15.3B. (January 2022)

Employee Data

  • Bio-Techne Corporation has 3270 Employees.(i)
  • Bio-Techne Corporation grew their employee count by 0% last year.

Bio-Techne Corporation's People

NameTitleEmail/Phone
1
Marketing Director - Digital Product OwnerReveal Email/Phone
2
Global Marketing Campaign Manager/Product Owner - Spatial Biology/Gene TherapyReveal Email/Phone
3
Marketing Campaign Manager/Product OwnerReveal Email/Phone
4
SVP | Chief Human Resources OfficerReveal Email/Phone
5
SVP – Chief Human Resources OfficerReveal Email/Phone
6
Chief Scientific Officer & Head Bioinformatics, Molecular Diagnostics DivisionReveal Email/Phone
7
SVPReveal Email/Phone
8
VP, Cell & Gene Therapy Business UnitReveal Email/Phone
9
VP, EMEAReveal Email/Phone
10
VP, Corp Quality and RegulatoryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M509%N/AN/A
#2
$7.4M48-35%N/AN/A
#3
$0.9M620%N/AN/A
#4
$0.3M2-91%N/AN/A
#5
$3.6M235%N/AN/A
#6
$0.9M6-33%N/AN/A
#7
$5M323%N/AN/A
#8
$14.7M959%N/AN/A
#9
$14.7M950%$20.5MN/A
#10
$27.9M14413%$39.1MN/A
Add Company

What Is Bio-Techne Corporation?

TECHNE Corporation (NASDAQ: TECH), incorporated in Minnesota in 1981, is a holding company which has two wholly-owned operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) located in Minneapolis, Minnesota and R&D Systems Europe Ltd. (RDSE) located in Abingdon, England. R&D Systems is a specialty manufacturer of biological products. It has two operating divisions: Hematology and Biotechnology. The Hematology Division develops and manufactures hematology controls, which are used in hospitals and clinical laboratories to check the accuracy of blood analysis instruments. The Biotechnology Division develops and manufactures biotechnology products including purified proteins (cytokines) and antibodies that are sold exclusively to the research market, and assay kits which are sold to the research and clinical diagnostic markets. Over 97% of TECHNE’s revenues are derived from products manufactured by R&D Systems. RDSE sells and distributes R&D Systems' biotechnology products in Europe. RDSE has a German sales subsidiary, R&D Systems GmbH. from products manufactured by R&D Systems. RDSE sells and distributes R&D Systems' biotechnology products in Europe. RDSE has a German sales subsidiary, R&D Systems GmbH.

keywords:N/A

N/A

Total Funding

3270

Number of Employees

$984.5M

Revenue (est)

0%

Employee Growth %

$15.3B

Valuation

N/A

Accelerator

Bio-Techne Corporation News

2022-04-19 - Bio-Techne (TECH) to Release Quarterly Earnings on ...

The company had revenue of $269.30 million during the quarter, compared to the consensus estimate of $266.57 million. Bio-Techne had a net...

2022-04-17 - BIO-TECHNE INCLUDED ON THE FORBES BEST ...

MINNEAPOLIS, April 26, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has been included on the Forbes...

2022-04-06 - BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF ...

MINNEAPOLIS, April 12, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cygnus Technologies, part of Maravai LifeSciences...

2021-11-08 - Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis

MINNEAPOLIS, Nov. 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Asuragen, Inc., a Bio-Techne brand, has launched a new kit to detect pathogenic variants in the CFTR gene. The AmplideX® PCR/CE CFTR Kit, intended for research use only, provides broader coverage ...

2021-11-03 - Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility

MINNEAPOLIS, Nov. 3, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the commercial availability of GMP-grade materials manufactured at its St. Paul, MN GMP (Good Manufacturing Practices) manufacturing facility. The facility is dedicated to supporting large-scale produ ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$687.6M33873%N/A
#2
$1557.4M41204%N/A
#3
$2260M45200%N/A
#4
$1920M52396%N/A
#5
$2145.2M56751%N/A